Coccidioidomycosis of the prostate gland: two cases and a review of the literature.Abstract: Coccidioidomycosis prostatitis is an uncommon presentation of disseminated coccidioidomycosis, a fungal disease endemic in the southwestern United States. Coccidioidomycosis prostatitis should be considered in the differential diagnosis of a patient from an endemic region with evidence of persistent sterile pyuria, prostatitis, or granulomatous disease of the prostate. Diagnosis is established by biopsy, and treatment includes either an azole or amphotericin B. We present the twelfth and thirteenth reported cases and provide a review of the literature. Key Words: acute splenic sequestration crisis, adults, sickle cell anemia ********** Coccidioidomycosis, or valley fever, is acquired by inhalation of arthroconidia in desert soil in the southwestern United States. Clinical manifestations are typically a flu-like illness or self-limited pneumonia; 1 to 5% of patients with the condition develop disseminated disease, which most commonly involves the skin, bones/joints, and central nervous system. Coccidioides immitis prostatitis is a rare form of disseminated coccidioidomycosis. To the best of our knowledge, only 11 antemortem cases of coccidioidomycosis prostatitis have been reported in the medical literature. We present the 12th and 13th cases and provide a review of the literature. Case Reports Patient 1 A 65-year-old black man presented to the urology clinic in August 1999 for evaluation of a prostate nodule and a rising prostate-specific antigen level that hadincreased from 2.0 ng/mL to 4.1 ng/mL. A prostate biopsyrevealed focal granulomatous inflammation, with fungal elements consistent with Coccidioides immitis (Fig. 1). The patient was lost to follow-up, without receiving any antifungal therapy. In November 2002, the patient presented to his primary care physician who, on review of the biopsy result, referred him to our infectious disease clinic for further evaluation. The patient had no complaints of dysuria, hematuria, frequency, or hesitancy. He reported no history of prior coccidioidomycosis or pulmonary complaints. The patient had spent his childhood in eastern Texas and moved to the Central Valley of California, where he lived for many years before moving to San Diego, CA, in 1978. He had a history of hypertension, hyperlipidemia, osteoarthritis, and a positive purified protein derivative test in 1968, for which he had received 1 year of isoniazid therapy. In August 2001, the patient had a 1-cm, flat, itchy "fungal infection" of the right buttock that resolved after 4 weeks of oral fluconazole at a dose of 200 mg weekly. Physical examination was unremarkable except for the prostate gland, which had a nodular surface but was nontender and not enlarged. The skin examination was normal. Complete blood count and chemistries were normal. Serum C. immitis enzyme immunoassay was positive for immunoglobulin G and immunoglobulin M, and his complement fixation (CF) titer was 1:64. Urinalysis revealed sterile pyuria, and urine fungal cultures grew C. immitis. Chest radiography revealed linear opacities extending from the left hilum, consistent with scarring, and a bone scan was normal. The patient was treated with oral fluconazole 800 mg daily and is currently well. Patient 2 A 53-year-old white man with adult-onset diabetes was evaluated in 1989 for epididymal and prostate masses. He was a long-term resident of southern California and had been an archeological student in the 1970s. Several of his classmates had developed coccidioidomycosis, but he had no clinical or skin test evidence of infection at that time. During the 1980s, he was repeatedly evaluated for neutrophilia of unknown cause. During an evaluation by a urologist in 1989, a prostate biopsy to evaluate for suspected prostate malignancy revealed granulomatous inflammation and C. immitis spherules. The patient denied any systemic complaints. The CF titer on diagnosis was 1:32, and a chest radiograph and bone scan were unremarkable. He was treated with daily oral fluconazole, with clinical resolution and decreasing CF titers. He is currently on fluconazole 400 mg/d, with a titer of less than 1:2. He remains asymptomatic with respect to his coccidioidomycosis after 10 years of follow-up. Discussion Coccidioidomycosis prostatitis is an uncommon presentation of disseminated coccidioidomycosis, a fungal disease endemic in the southwestern United States and parts of South and Central America. Coccidioidomycosis may affect any organ; however, the most common sites of dissemination include the skin, bones, joints, and meninges. Genitourinary coccidioidomycosis, a form of disseminated disease, may involve the prostate, kidneys, bladder, and reproductive organs, and may go undiagnosed among patients with more prominent signs of disseminated disease in other organs. The kidney is the sixth most common site of dissemination, and Forbus and Bestebreurtje (1) found renal involvement in up to 60% of patients with disseminated disease at autopsy--6% had prostatic disease. Prostate involvement is rarely recognized antemortem. We performed a MEDLINE search of the English literature from 1966 to 2002 and examined the Index Medicus from 1940 to 1966 using the search terms "coccidioidomycosis," "prostate," "prostatitis," and "genitourinary." McDougall and Kleinman (2) described the first antemortem case of coccidioidomycosis prostatitis in 1943, and an additional 12 cases have been added to the medical literature, including the two cases we present here (Table 1). (2-11) The median age at the time of diagnosis of coccidioidomycosis prostatitis was 62 years (range, 44-72 years). Sixty-two percent of the patients were white, 15% were black, 15% were Hispanic, and 8% were Filipino. [FIGURE 1 OMITTED] Coccidioidomycosis prostatitis may be asymptomatic or may present with symptoms attributed to the urinary system. Of the 13 antemortem reported cases, 5 (38%) reported no urologic symptoms, 4 (31%) had symptoms of bladder outlet obstruction, 1 (8%) reported hematuria, and 1 (8%) reported an epididymal mass; in 2 (15%), symptoms were not reported. Prostate examination may be normal or may reveal tenderness, bogginess, firmness, or the presence of one or more nodules. Of the 11 cases that included a description of the prostate examination, prostatic enlargement was reported in 6 (55%), prostate nodules in 4 (36%), and a normal prostate examination in 1 (9%). The prostate-specific antigen level is frequently elevated as a result of the local inflammation caused by the fungal infection. Urinalysis is often abnormal; of the 10 patients with a documented urinalysis, 6 (60%) had pyuria, 1 (10%) had hematuria, 1 (10%) had bacteruria, and 2 (20%) had normal specimens. Characteristic C. immitis spherules may be visualized in concentrated urine specimens, expressed prostatic secretions or, more commonly, in biopsy specimens. The organism may also be grown in culture from any of the above specimens. C. immitis grew in urine fungal cultures in 5 of 13 cases (38%). Definitive diagnosis, however, is made by pathologic tissue examination in which the characteristic endospore-containing spherules are seen. Periodic acid-Schiff (PAS) and silver-methenamine stains are the most reliable, although the organism may at times be seen with a routine hematoxylin and eosin stain. CF titers were reported in 10 of the patients, and 6 of 10 (60%) had a coccidioides CF titer greater than or equal to 1:32. Radiographic studies are not helpful in the diagnosis of coccidioidomycosis prostatitis. There are no specific guidelines for the treatment of coccidioidomycosis prostatitis; however, daily oral fluconazole 800 mg followed by long-term suppressive therapy is advocated. For disseminated disease involving other extrapulmonary sites, initial intravenous amphotericin B is usually indicated. Although surgical procedures are occasionally indicated for symptomatic or concomitant disease, such procedures are not typically curative, and adjunctive systemic antifungal therapy is indicated. Regular monitoring of serum coccidioides CF titers is warranted to follow the response to therapy. Conclusion Coccidioidomycosis prostatitis, although uncommon, should be considered in the differential diagnosis of any patient from an endemic region with evidence of persistent sterile pyuria, prostatitis, or granulomatous disease of the prostate. If identified, coccidioidomycosis prostatitis should be treated aggressively, as it always represents disseminated disease.
Table 1. Coccidioidomycosis of the prostate, 1940-2002 (a)
Time from
initial
diagnosis
Series Age to prostate
Case (ref. no.) (yr) Race Symptoms/signs involvement
1 McDougall 52 White Hematuria, history Unclear
and of cough,
Kleimar, sweats, weight
1943 (2) loss
2 Gritti et al, 48 White Weight loss, knee Unclear
1963 (3) pain
3 Bellin and 72 White Outlet obstruction None
Bhavan,
1973 (4)
4 Gottesman, 72 White Urgency, outlet None
1974 (5) obstruction
5 Petersen et 44 Black NR Unclear
al, 1976
(6)
6 Petersen et 45 White NR Unclear
al, 1976
(6)
7 Sung et al, 62 Mexican Hemoptysis 6 yr earlier
1979 (7)
8 Price et al, 72 Filipino Weight loss, Same time
1982 (8) urinary
obstructive
symptoms
9 Chen and 67 White Nocturia, urinary 20 yr
Schiff, obstructive
1985 (9) symptoms
10 Niku et al, 54 White Weight loss and Earlier date
1998 (10) cough
11 Lawrence et 62 Cuban None 4 yr
al, 1999
(11)
12 Truett and 65 Black None Same time
Crum,
2004
(present
study)
13 Truett and 53 White Epididymal mass Same time
Crum,
2004
(present
study)
Sites of
Series nongenitourinary
Case (ref. No.) involvement Examination Urinalysis
1 McDougall Meninges, knee, Enlarged, Hematuria
and possibly lung asymmetric
Kleimar, prostate
1943 (2)
2 Gritti et al, Lung, knee Prostate Normal
1963 (3) nodule
3 Berlin and None Enlarged Pyuria
Bhavan, prostate
(1973) (4) with hard
areas
4 Gottesman, None Normal Bacteriuria
(1974) (5)
5 Petersen et Lung, meninges, NR Pyuria and
al, 1976 spleen proteinuria
(6)
6 Petersen et Lung, meninges, NR Pyuria and
al, 1976 spleen proteinuria
(6)
7 Sung et al, Possibly lung Tender, nodular Pyuria
(1979) (7) prostate
8 Price et al, None Diffusely NR
(1982) (8) enlarged
prostate
9 Chen and Pulmonary Diffusely Pyuria
Schiff, enlarged
(1985) (9) prostate
10 Niku et al, Possibly lung Enlarged NR
(1998) (10) prostate
11 Lawrence et None Firm prostate NR
al, 1999 with nodule
(11)
12 Truett and Possibly lung Prostate Pyuria
Crum, nodule
2004
(present
study)
13 Truett and None Enlarged, Normal
Crum, hard
2004 prostate
(present
study)
Series PSA CF Cultures/
Case (ref. No.) (ng/ml) titer pathologic findings
1 McDougall NR NR Spherules on
and prostate abscess
Kleimar, drainage; positive
1943 (2) urine cultures
2 Gritti et al, NR 1: Spherules on
1963 (3) 16 prostate biopsy
3 Bellin and NR 1: Spherules on TURP
Bhavan, 64 specimen (b)
1973 (4)
4 Gottesman, NR 1:1 Spherules on
1974 (5) prostatectomy
specimen
5 Petersenet NR 1: Spherules on
al, 1976 128 prostate biopsy;
(6) positive urine
cultures
6 Petersen et NR 1: Spherules on
al, 1976 64 prostate abscess
(6) drainage; positive
urine cultures
7 Sung et al, NR 1: Spherules on
1979 (7) 128 prostate biopsy;
positive urine
cultures
8 Price et al, NR 1:4 Spherules on TURP
1982 (8) specimen; no
cultures
9 Chen and NR 1: Spherules on TURP
Schiff, 16 specimen; no
1985 (9) cultures
10 Niku et al, 9.2 NR Spherules on
1998 (10) prostatectomy
specimen (b)
11 Lawrence et 14.7 NR Spherules on
al, 1999 prostatectomy
(11) specimen (b)
12 Truett and 4.1 1: Spherules on
Crum, 64 prostate biopsy
2004 specimen:
(present positive urine
study) cultures
13 Truett and NP 1: Spherules on
Crum, 32 prostate biopsy
2004 specimen
(present
study)
Series Chest
Case (ref. no.) radiograph Therapy Outcome
1 McDougall Atypical Neoprontosil Died as a
and tuberculosis result of
Kleimar, meningitis
1943 (2)
2 Gritti et al, Coin lesion Amphotericin B No follow-up
1963 (3)
3 Bellin and Pulmonary Transurethral No follow-up
Bhavan, fibrosis resection
1973 (4) with
bilateral
pleural
effusions
4 Gottesman, NR Amphotericin B Well at 6 mo
1974 (5)
5 Petersen et NR Amphotericin B Died
al, 1976
(6)
6 Petersen et NR Amphotericin B Died
al, 1976
(6)
7 Sung et al, Normal Amphotericin B Well at 8 mo
1979 (7) 2.5 g and
transurethral
resection
8 Price et al, Normal Amphotericin Well
1982 (8) 800 mg and
transurethral
resection
9 Chen and Normal; Ketoconazole Well at 18 mo
Schiff, history
1985 (9) of pneumonia
10 Niku et al, NR Fluconazole Well
1998 (10) 800 PO
every day
11 Lawrence et NR Antifungal oral Well
al, 1999 medication
(11)
12 Truett and Hilar scarring Fluconazole Well at 3
Crum, 800 mg/d mo
2004
(present
study)
13 Truett and Normal Fluconazole Well at 10
Crum, 400 mg/d yr
2004
(present
study)
(a) NR, not reported; NP, not performed; TURP, transurethral
prostatectomy.
(b) Also diagnosed with prostate adenocarcinoma.
Acknowledgment The authors would like to express their gratitude to Dr. Mark Wallace for his critical review of the manuscript. Accepted October 22, 2003. Copyright [c] 2004 by The Southern Medical Association 0038-4348/04/9704-0419 References 1. Forbus WD, Bestebreurtje AM. Coccidioidomycosis: A study of 95 cases of the disseminated type with special reference to the pathogenesis of the disease. Mil Surg 1946:99:653-671. 2. McDougall TG, Kleiman AH. Prostatitis due to Coccidioides immitis. J Urol 1943:49:472-477. 3. Gritti EJ, Cook FE Jr, Spencer HB. Coccidioidomycosis granuloma of the prostate: A rare manifestation of the disseminated disease. J Urol 1963;89:249-252. 4. Bellin HJ, Bhagavan BS. Coccidioidomycosis of the prostate gland: Report of a case and review of the literature. Arch Pathol 1973;96:114-117. 5. Gottesman JE. Coccidioidomycosis of prostate and epididymis: With urethrocutaneous fistula. Urology 1974;4:311-314. 6. Petersen EA, Friedman BA, Crowder ED, et al. Coccidoidouria: Clinical significance. Ann Intern Med 1976;85:34-38. 7. Sung JP, Sun SS, Crutchlow PF. Coccidioidomycosis of the prostate gland and its therapy. J Urol 1979;121:127-128. 8. Price MJ, Lewis EL, Carmalt JE. Coccidioidomycosis of prostate gland. Urology 1982;19:653-655. 9. Chen KT, Schiff JJ. Coccidioidomycosis of prostate. Urology 1985;25:82-84. 10. Niku SD, Dalgleish G, Devendra G. Coccidioidomycosis of the prostate gland. Urology 1998;52:127. 11. Lawrence MA, Ginsberg D, Stein JP, et al. Coccidioidomycosis prostatitis associated with prostate cancer. BJU Int 1999;84:372-373. RELATED ARTICLE: Key Points * Coccidioidomycosis, commonly referred to as valley fever, typically presents as a self-limited respiratory infection, but may disseminate to any location, including the genitourinary tract. * Coccidioidomycosis prostatitis should be considered in patients presenting with a prostate nodule or sterile pyuria who have resided in or traveled to the southwestern United States. * The diagnosis of Coccidioides immitis infection of the prostate is established by prostate biopsy, and treatment consists of antifungal agents such as fluconazole or amphotericin B. April A. Truett, MD, and Nancy F. Crum, MD, MPH From the Infectious Diseases Division, Naval Medical Center San Diego, San Diego, CA. The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy, Department of Defense, or the United States Government. Reprint requests to April A. Truett, MD, Clinical Investigation Department (KCA), Naval Medical Center San Diego, 34800 Bob Wilson Drive, Suite 5, San Diego, CA 92134-1005. Email: aatruett@nmcsd.med.navy.mil |
|
||||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion